Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Sleep Hypn. 2020; 22(1): 1-7


Efficacy of Modafinil for Dissociative Identity Disorder with Hypersomnia

Adriana Fiszman, Ivan Figueira, Camilla Pinna, Claudia Cecilia da Silva Rego, Soniza Vieira Alves-Leon, Carlos H. Schenck.




Abstract

We report the case of a 22-year-old female victim of childhood sexual abuse with dissociative identity disorder and hypersomnia who remitted from both clinical conditions with the use of modafinil 400 mg/day. We review the literature supporting the sleep-dissociation theory, where trauma-related memories induce a labile sleep-wake cycle allowing dreamlike mentation to intrude into waking consciousness and precipitate dissociative symptoms. The studies examined here found high correlations between dissociation and unusual sleep experiences. This may explain why in our case report modafinil, a medication with wake-promoting properties, improved both excessive daytime sleepiness and dissociation. Future studies are needed to determine which alterations in the sleep-wake cycle are most associated with dissociative disorders. We suggest a new perspective on the use of medications for comorbid hypersomnia, such as modafinil, in the treatment of dissociation.

Key words: Dissociative disorders, excessive daytime sleepiness, sleep disorders, psychopharmacology, childhood sexual abuse






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.